Friday, April 10, 2020 5:29:14 PM
I cannot say why the company did as they did, other than perhaps the belief that PLX-PAD was closer to approval. I frankly believe the U.S. Govt. based on animal trials for radiation could declare PLX-R18 approved, essentially as a cover my ass way to make it available for use off label immediately. I don't know that PSTI has filed for such approval, but when it comes to CMA solutions to problems, perhaps that could be ignored at this time.
We know the drug is being used in human trials for other things, but none are close to approval, agencies like the FDA want coverage for saying they're okay with using a product off label. An approval for use in radiation, based on purely animal trials would provide them such coverage.
Gary
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM